danazol has been researched along with Cardiac Failure in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Ather, A; Birks, EJ; Gerrald, JE; Kolodziej, AR; Kuan, W; Schadler, A | 1 |
Madan, S; Mehra, MR | 1 |
Asleh, R; Bawardy, BA; Pereira, N; Rajan, E; Schettle, S; Sherazi, S; Stulak, J | 1 |
Pereira, NL; Pruthi, RK; Schettle, SD | 1 |
Ghosh, K; Iyer, Y; Jijina, F; Madkaikar, M; Mohanty, D; Pathare, A | 1 |
5 other study(ies) available for danazol and Cardiac Failure
Article | Year |
---|---|
Retrospective review of secondary prevention strategies for gastrointestinal bleeding and associated clinical outcomes in left ventricular assist device patients.
Topics: Danazol; Gastrointestinal Hemorrhage; Heart Failure; Heart-Assist Devices; Hemostatics; Humans; Retrospective Studies; Secondary Prevention; Thromboembolism | 2022 |
Rhabdomyolysis with the combined use of danazol and rosuvastatin in left ventricular assist devices.
Topics: Adult; Comorbidity; COVID-19; Danazol; Drug Therapy, Combination; Estrogen Antagonists; Heart Failure; Heart-Assist Devices; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Rhabdomyolysis; Rosuvastatin Calcium; Treatment Outcome | 2020 |
Danazol treatment of gastrointestinal bleeding in left ventricular assist device-supported patients.
Topics: Administration, Oral; Aged; Angiodysplasia; Blood Transfusion; Cohort Studies; Danazol; Female; Gastrointestinal Hemorrhage; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Postoperative Complications; Recurrence | 2018 |
Continuous-flow left ventricular assist devices and gastrointestinal bleeding: potential role of danazol.
Topics: Danazol; Estrogen Antagonists; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged | 2014 |
Systemic capillary leak syndrome preceding plasma cell leukaemia.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Capillary Leak Syndrome; Combined Modality Therapy; Danazol; Dexamethasone; Doxorubicin; Fatal Outcome; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin G; Leukemia, Plasma Cell; Male; Neoplasm Proteins; Pentoxifylline; Plasma Cells; Preleukemia; Recurrence; Vincristine; Weight Gain | 2001 |